Microarray analysis: First‐trimester maternal serum free β‐hCG and the risk of significant copy number variants. (21st September 2018)
- Record Type:
- Journal Article
- Title:
- Microarray analysis: First‐trimester maternal serum free β‐hCG and the risk of significant copy number variants. (21st September 2018)
- Main Title:
- Microarray analysis: First‐trimester maternal serum free β‐hCG and the risk of significant copy number variants
- Authors:
- Bornstein, Eran
Gulersen, Moti
Krantz, David
Cheung, Sau W.
Maliszewski, Kristen
Divon, Michael Y. - Abstract:
- Abstract: Objective: To determine whether abnormal levels of first‐trimester maternal serum free β‐hCG and PAPP‐A are associated with significant copy number variants (CNVs) on chromosomal microarray analysis (CMA). Methods: Retrospective cohort of singleton prenatal CMA studies (n = 2880). Cases with an abnormal karyotype, benign familial or de novo variants, and absence of heterozygosity were excluded. The prevalence of abnormal serum analytes was compared between patients with significant CNVs (n = 56) and those with normal CMA (n = 884). Odds ratios (ORs) and 95% confidence intervals (CI) were calculated using Fisher's exact test. Mantel‐Haenszel method was utilized to adjust ORs for prenatal diagnostic procedure type and indications for testing. Statistical significance was determined as P value < 0.05. Results: Abnormally low serum free β‐hCG (≤0.45 MoM) was associated with an increased risk of significant CNVs (OR 3.53, 95% CI, 1.25‐8.66, P < 0.01). This association remained significant after adjusting for abnormal nuchal translucency and advanced maternal age (AMA) (adjusted OR 3.04, 95% CI, 1.05‐7.48, P < 0.05) or procedure type and AMA (adjusted OR 3.21, 95% CI 1.13–8.16, P < 0.05). The associations of abnormally high serum free β‐hCG, low PAPP‐A, and high PAPP‐A with significant CNVs were not statistically significant. Conclusion: Low first‐trimester serum β‐hCG is associated with an increased risk of significant CNVs on CMA. Abstract : What's already knownAbstract: Objective: To determine whether abnormal levels of first‐trimester maternal serum free β‐hCG and PAPP‐A are associated with significant copy number variants (CNVs) on chromosomal microarray analysis (CMA). Methods: Retrospective cohort of singleton prenatal CMA studies (n = 2880). Cases with an abnormal karyotype, benign familial or de novo variants, and absence of heterozygosity were excluded. The prevalence of abnormal serum analytes was compared between patients with significant CNVs (n = 56) and those with normal CMA (n = 884). Odds ratios (ORs) and 95% confidence intervals (CI) were calculated using Fisher's exact test. Mantel‐Haenszel method was utilized to adjust ORs for prenatal diagnostic procedure type and indications for testing. Statistical significance was determined as P value < 0.05. Results: Abnormally low serum free β‐hCG (≤0.45 MoM) was associated with an increased risk of significant CNVs (OR 3.53, 95% CI, 1.25‐8.66, P < 0.01). This association remained significant after adjusting for abnormal nuchal translucency and advanced maternal age (AMA) (adjusted OR 3.04, 95% CI, 1.05‐7.48, P < 0.05) or procedure type and AMA (adjusted OR 3.21, 95% CI 1.13–8.16, P < 0.05). The associations of abnormally high serum free β‐hCG, low PAPP‐A, and high PAPP‐A with significant CNVs were not statistically significant. Conclusion: Low first‐trimester serum β‐hCG is associated with an increased risk of significant CNVs on CMA. Abstract : What's already known about this topic? Abnormal levels of first‐trimester maternal serum free β‐hCG and PAPP‐A are associated with an increased risk of fetal aneuploidy. Fetal structural malformations and abnormal nuchal translucency are associated with an increased risk of significant copy number variants (CNVs) on microarray analysis. What does this study add? Abnormally low levels of first‐trimester maternal serum free β‐hCG is associated with an increased risk of significant CNVs on microarray analysis. … (more)
- Is Part Of:
- Prenatal diagnosis. Volume 38:Number 12(2018)
- Journal:
- Prenatal diagnosis
- Issue:
- Volume 38:Number 12(2018)
- Issue Display:
- Volume 38, Issue 12 (2018)
- Year:
- 2018
- Volume:
- 38
- Issue:
- 12
- Issue Sort Value:
- 2018-0038-0012-0000
- Page Start:
- 971
- Page End:
- 978
- Publication Date:
- 2018-09-21
- Subjects:
- Prenatal diagnosis -- Periodicals
Fetus -- Diseases -- Diagnosis -- Periodicals
Electronic journals
618.32075 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/pd.5350 ↗
- Languages:
- English
- ISSNs:
- 0197-3851
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6607.646000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 11325.xml